BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16862848)

  • 1. [HCV virus: virological aspects and laboratory diagnosis].
    González J; Fay F
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S18-20; discussion S74-82. PubMed ID: 16862848
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro replication models for the hepatitis C virus.
    Sheehy P; Mullan B; Moreau I; Kenny-Walsh E; Shanahan F; Scallan M; Fanning LJ
    J Viral Hepat; 2007 Jan; 14(1):2-10. PubMed ID: 17212638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PKR protein kinase is activated by hepatitis C virus and inhibits viral replication through translational control.
    Kang JI; Kwon SN; Park SH; Kim YK; Choi SY; Kim JP; Ahn BY
    Virus Res; 2009 Jun; 142(1-2):51-6. PubMed ID: 19189853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus replication in patients with occult hepatitis C virus infection.
    Carreño V; Bartolomé J; Castillo I; Quiroga JA
    Hepatology; 2009 Jun; 49(6):2128-9; author reply 2129. PubMed ID: 19475689
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hepatitis C virus--structure, replication and therapeutical opportunities and the phenomenon of resistance].
    Kowala-Piaskowska A
    Postepy Biochem; 2006; 52(4):399-407. PubMed ID: 17536509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV.
    Deterding K; Tegtmeyer B; Cornberg M; Hadem J; Potthoff A; Böker KH; Tillmann HL; Manns MP; Wedemeyer H
    J Hepatol; 2006 Dec; 45(6):770-8. PubMed ID: 17034895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New efficient replication system with hepatitis C virus genome derived from a patient with acute hepatitis C.
    Mori K; Abe K; Dansako H; Ariumi Y; Ikeda M; Kato N
    Biochem Biophys Res Commun; 2008 Jun; 371(1):104-9. PubMed ID: 18406345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virology and pathogenesis of hepatitis C virus recurrence.
    Ramírez S; Pérez-Del-Pulgar S; Forns X
    Liver Transpl; 2008 Oct; 14 Suppl 2():S27-35. PubMed ID: 18825723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and molecular biology of HCV infection and hepatitis.
    Tang H; Grisé H
    Clin Sci (Lond); 2009 Jun; 117(2):49-65. PubMed ID: 19515018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bad time for Bonzo? Experimental models of hepatitis C virus infection, replication, and pathogenesis.
    Grakoui A; Hanson HL; Rice CM
    Hepatology; 2001 Mar; 33(3):489-95. PubMed ID: 11230726
    [No Abstract]   [Full Text] [Related]  

  • 11. The hepatitis C virus life cycle as a target for new antiviral therapies.
    Pawlotsky JM; Chevaliez S; McHutchison JG
    Gastroenterology; 2007 May; 132(5):1979-98. PubMed ID: 17484890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Of mice and men: a small animal model of hepatitis C virus replication.
    Brass V; Blum HE; Moradpour D
    Hepatology; 2002 Mar; 35(3):722-4. PubMed ID: 11870390
    [No Abstract]   [Full Text] [Related]  

  • 13. Replication of hepatitis C virus.
    Moradpour D; Penin F; Rice CM
    Nat Rev Microbiol; 2007 Jun; 5(6):453-63. PubMed ID: 17487147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus genetic variability in patients undergoing antiviral therapy.
    Cristina J; del Pilar Moreno M; Moratorio G
    Virus Res; 2007 Aug; 127(2):185-94. PubMed ID: 17449128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opiate abuse and viral replication in hepatitis C.
    Moore K; Dusheiko G
    Am J Pathol; 2005 Nov; 167(5):1189-91. PubMed ID: 16251404
    [No Abstract]   [Full Text] [Related]  

  • 16. Additive effect of ethanol and HCV subgenomic replicon expression on COX-2 protein levels and activity.
    Trujillo-Murillo K; Alvarez-Martínez O; Garza-Rodríguez L; Martínez-Rodríguez H; Bosques-Padilla F; Ramos-Jiménez J; Barrera-Saldaña H; Rincón-Sánchez AR; Rivas-Estilla AM
    J Viral Hepat; 2007 Sep; 14(9):608-17. PubMed ID: 17697012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of hepatitis C virus replication and expression by small interfering RNA targeting host cellular genes.
    Xue Q; Ding H; Liu M; Zhao P; Gao J; Ren H; Liu Y; Qi ZT
    Arch Virol; 2007; 152(5):955-62. PubMed ID: 17273891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary cultures of human hepatocytes isolated from hepatitis C virus-infected cirrhotic livers as a model to study hepatitis C infection.
    Raymond VA; Selliah S; Ethier C; Houle R; Jouan L; Maniere T; Lamarre D; Willems B; Bilodeau M
    Liver Int; 2009 Jul; 29(6):942-9. PubMed ID: 19302183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus entry: an intriguing challenge for drug discovery.
    Meanwell NA
    Curr Opin Investig Drugs; 2006 Aug; 7(8):727-32. PubMed ID: 16955684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro replicative properties of replicons constructed using sequence variants of the hepatitis C virus strain AD78 that caused a single-source outbreak of hepatitis C.
    Oniangue-Ndza C; Aus dem Siepen M; Lohmann V; Wiese M; Viazov S; Roggendorf M
    Virus Res; 2009 Jun; 142(1-2):1-9. PubMed ID: 19103237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.